Medicine
Memantine 7 mg extended-release capsule
Memantine 7 mg extended-release capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store memantine hydrochloride extended-release capsules at 20° to 25°C (68° to…
Key facts
- Active ingredient (INN)
- Memantine
- Brand
- Sold under the generic name
- Strength
- 7 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 30 capsules, 90 capsules, 10 blister pack and 15 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaLupinIndiaAmneal PharmaceuticalsMajor PharmaceuticalsRising Pharma HoldingsSlate Run PharmaceuticalsVitruvias Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store memantine hydrochloride extended-release capsules at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06DX01 Memantine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 December 2017
- Identifiers
- RxCUI 996594, 996603, 996609 +2DailyMed set ID ec825bef-2313-45c2-8858-b43197680155, 2b2dcd54-47e0-494b-85d2-c28c3adbe737, eac265e6-6ea4-4368-acff-2efe6a8dd40a +7NDC 70771-1321, 59651-404, 68382-546 +7Application ANDA203293, ANDA214651, ANDA213985 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule, extended release in 1 bottle | 68382-546-06 | Zydus LifesciencesIndia | 8 April 2018 |
| 90 capsule, extended release in 1 bottle | 68382-546-16 | Zydus LifesciencesIndia | 8 April 2018 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 68382-546-77 | Zydus LifesciencesIndia | 8 April 2018 |
| 30 capsule, extended release in 1 bottle | 70771-1321-3 | Zydus LifesciencesIndia | 8 April 2018 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 70771-1321-4 | Zydus LifesciencesIndia | 8 April 2018 |
| 90 capsule, extended release in 1 bottle | 70771-1321-9 | Zydus LifesciencesIndia | 8 April 2018 |
| 30 capsule, extended release in 1 bottle | 59651-404-30 | Aurobindo PharmaIndia | 9 August 2021 |
| 90 capsule, extended release in 1 bottle | 59651-404-90 | Aurobindo PharmaIndia | 9 August 2021 |
| 30 capsule, extended release in 1 bottle | 68180-246-06 | LupinIndia | 20 February 2018 |
| 30 capsule, extended release in 1 bottle | 33342-219-07 | Macleods PharmaceuticalsIndia | 28 August 2025 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 33342-219-12 | Macleods PharmaceuticalsIndia | 28 August 2025 |
| 30 capsule, extended release in 1 bottle | 65162-782-03 | Amneal Pharmaceuticals | 22 December 2017 |
| 90 capsule, extended release in 1 bottle | 65162-782-09 | Amneal Pharmaceuticals | 22 December 2017 |
| 500 capsule, extended release in 1 bottle | 65162-782-50 | Amneal Pharmaceuticals | 22 December 2017 |
| 30 capsule, extended release in 1 bottle, plastic | 16571-852-03 | Rising Pharma Holdings | 1 June 2025 |
| 30 capsule, extended release in 1 bottle | 70436-054-04 | Slate Run Pharmaceuticals | 15 November 2021 |
| 30 capsule, extended release in 1 bottle | 69680-161-30 | Vitruvias Therapeutics | 15 December 2023 |
| 100 blister pack in 1 carton / 1 capsule, extended release in 1 blister pack | 0904-6734-61 | Major Pharmaceuticals | 20 February 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Memantine
Clinical summary
Memantine is a N-methyl-D-aspartate receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. It is available as tablets, extended-release capsules and oral solution. MedsAcross supplies Memantine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MemantineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- memantine hydrochloride prescribing information (Actavis Pharma) · U.S. National Library of Medicine, DailyMed
- Axura: European public assessment report (EPAR) · European Medicines Agency
- Ebixa: European public assessment report (EPAR) · European Medicines Agency
Need Memantine 7 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.